Neuphoria Therapeutics Inc. (NEUP)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 31
+0.07
+2.1605%
$
18.16M Market Cap
- P/E Ratio
- Div Yield
18,700 Volume
- Eps
$ 3.24
Previous Close Investors:
Want to track NEUP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neuphoria Therapeutics Inc. (NEUP) Statistics
Valuation metrics
Market Cap 18.16M
Enterprise value -1.67M
Trailing P/E (ttm) -0.46
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 15.47
Price/Book (mrq) 0.74
Enterprise Value/Revenue -1.42
Enterprise Value/EBITDA 0.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.5K
Average volume (90 days) 664.66K
Price summary
52-Week low 3.19
52-Week high 17.9
Beta -
50-Day moving average 3.62
200-Day moving average 4.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 24 Dec 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -15.78%
Operating margin -11.88%
Operational effectiveness
Return on assets -0.65%
Return on equity -0.77%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.42
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 27.85%
Book value per share (mrq) 4.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
